Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2431-2440 of 2762 for

Edit search filters
  1. A Study to Determine the Effects of COVID-19 in Cancer Patients

    Scottsdale/Phoenix, AZ, Mankato, MN, La Crosse, WI, Eau Claire, WI, Rochester, MN

  2. Spinal Cord Stimulation to Treat Chemotherapy-Induced Peripheral Neuropathy

    Rochester, MN

  3. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker

    Jacksonville, FL

  4. A Registry of Patient Data and DNA Samples for Early Detection of Radiation Related Side Effects

    Jacksonville, FL

  5. A Study of Sinonasal Carcinomas at Mayo Clinic Rochester

    Rochester, MN

  6. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC

    Rochester, MN

  7. A Study to Understand Symptoms from Olaparib

    Rochester, MN

  8. Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

    Rochester, MN

  9. Correlative Biomarker Study in Patients With Myeloproliferative Disorders

    Scottsdale/Phoenix, AZ

  10. Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer